Amicus Therapeutics Inc. buy BiotechBee
Start price
13.01.23
/
50%
€11.78
Target price
31.05.24
€17.00
Performance (%)
-9.18%
End price
05.05.23
€10.70
Summary
This prediction ended on 05.05.23 with a price of €10.70. With a performance of -9.18%, the BUY prediction for Amicus Therapeutics Inc. by BiotechBee closed slightly in the red. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Amicus Therapeutics Inc. | -0.532% | -0.532% | -22.083% |
iShares Core DAX® | -0.598% | 0.645% | 10.813% |
iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% |
iShares Nikkei 225® | -0.796% | -0.582% | 8.390% |
iShares S&P 500 | -1.164% | -0.857% | 23.003% |
According to BiotechBee what are the pros and cons of Amicus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Buy mit Kursziel 17,0
In the thread Trading Amicus Therapeutics Inc.
Buy beendet